Method AI: $20 Million Series A Secured To Enhance Physician Visualization During Surgical Oncology Procedures

Method AI, a medical technology innovator dedicated to advancing oncology outcomes, has secured $20 million in Series A funding to further develop its pioneering surgical ultrasound platform. Originating from Cleveland Clinic in 2021, Method AI was founded in response to challenges faced by leading robotic surgeons, who struggled with inadequate visualization of subsurface anatomy during complex surgical oncology procedures.